Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.

The Journal of Biological Chemistry
Li LiuJianchang Yang

Abstract

All-trans retinoic acid (ATRA) is a differentiation agent that revolutionized the treatment of acute promyelocytic leukemia. However, it has not been useful for other types of acute myeloid leukemia (AML). Here we explored the effect of SALL4, a stem cell factor, on ATRA-induced AML differentiation in both ATRA-sensitive and ATRA-resistant AML cells. Aberrant SALL4 expression has been found in nearly all human AML cases, whereas, in normal bone marrow and peripheral blood cells, its expression is only restricted to hematopoietic stem/progenitor cells. We reason that, in AMLs, SALL4 activation may prevent cell differentiation and/or protect self-renewal that is seen in normal hematopoietic stem/progenitor cells. Indeed, our studies show that ATRA-mediated myeloid differentiation can be largely blocked by exogenous expression of SALL4, whereas ATRA plus SALL4 knockdown causes significantly increased AML differentiation and cell death. Mechanistic studies indicate that SALL4 directly associates with retinoic acid receptor α and modulates ATRA target gene expression. SALL4 is shown to recruit lysine-specific histone demethylase 1 (LSD1) to target genes and alter the histone methylation status. Furthermore, coinhibition of LSD1 and ...Continue Reading

References

Mar 21, 2002·Nature Reviews. Cancer·L Altucci, H Gronemeyer
Oct 24, 2002·American Journal of Human Genetics·Raidah Al-BaradieElizabeth C Engle
Jul 7, 2005·Blood·Kimberly StegmaierTodd R Golub
Jul 15, 2006·The Journal of Biological Chemistry·Qiang WuHuck-Hui Ng
Dec 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jianchang YangYupo Ma
Feb 3, 2009·Gastroenterology·Tsunekazu OikawaHiromitsu Nakauchi
Nov 3, 2009·The Journal of Biological Chemistry·Sang-Wang LeeSoo-Jong Um
Sep 29, 2011·Journal of Hematology & Oncology·Jianchang YangYupo Ma
Oct 25, 2011·Nature Cell Biology·Iris UribesalgoLuciano Di Croce
Dec 1, 2011·The Journal of Biological Chemistry·Jianchang YangYupo Ma
May 5, 2012·Current Opinion in Hematology·Jianchang YangYupo Ma
Sep 10, 2013·Journal of Hepatology·Sha Sha ZengShuichi Kaneko
Sep 25, 2014·Developmental Biology·Joanne G A SavoryDavid Lohnes
Dec 3, 2014·Cancer Letters·Xu ZhangWenrong Xu

❮ Previous
Next ❯

Citations

Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ebubekir Dirican, Mustafa Akkiprik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.